Singulair (Montelukast Tablets) and Tezacaftor/ivacaftor and ivacaftor
Determining the interaction of Singulair (Montelukast Tablets) and Tezacaftor/ivacaftor and ivacaftor and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.MONITOR: Coadministration with inhibitors of CYP450 2C8 and/or 2C9 may increase the plasma concentrations of montelukast, which is metabolized by these isoenzymes in addition to CYP450 3A4. When montelukast was administered with the potent CYP450 2C8/2C9 inhibitor gemfibrozil, montelukast systemic exposure (AUC) increased by 4.4-fold. The addition of itraconazole, a potent CYP450 3A4 inhibitor, to gemfibrozil and montelukast did not further increase the AUC of montelukast. Administration of itraconazole alone with montelukast also resulted in no significant increase in the AUC of montelukast, which would suggest that montelukast is primarily metabolized by CYP450 2C8 and 2C9 in vivo. MANAGEMENT: According to the product labeling, no dosage adjustment of montelukast is required when used in combination with gemfibrozil. However, it may be advisable to monitor patients for potentially increased adverse effects during coadministration with gemfibrozil or other CYP450 2C8/2C9 inhibitors. References "Product Information. Singulair (montelukast)." Merck & Co, Inc, West Point, PA. Karonen T, Filppula A, Laitila J, Niemi M, Neuvonen PJ, Backman JT "Gemfibrozil Markedly Increases the Plasma Concentrations of Montelukast: A Previously Unrecognized Role for CYP2C8 in the Metabolism of Montelukast." Clin Pharmacol Ther (2010):
Professional:MONITOR: Coadministration with inhibitors of CYP450 2C8 and/or 2C9 may increase the plasma concentrations of montelukast, which is metabolized by these isoenzymes in addition to CYP450 3A4. When montelukast was administered with the potent CYP450 2C8/2C9 inhibitor gemfibrozil, montelukast systemic exposure (AUC) increased by 4.4-fold. The addition of itraconazole, a potent CYP450 3A4 inhibitor, to gemfibrozil and montelukast did not further increase the AUC of montelukast. Administration of itraconazole alone with montelukast also resulted in no significant increase in the AUC of montelukast, which would suggest that montelukast is primarily metabolized by CYP450 2C8 and 2C9 in vivo.
MANAGEMENT: According to the product labeling, no dosage adjustment of montelukast is required when used in combination with gemfibrozil. However, it may be advisable to monitor patients for potentially increased adverse effects during coadministration with gemfibrozil or other CYP450 2C8/2C9 inhibitors.
- "Product Information. Singulair (montelukast)." Merck & Co, Inc, West Point, PA.
- Karonen T, Filppula A, Laitila J, Niemi M, Neuvonen PJ, Backman JT "Gemfibrozil Markedly Increases the Plasma Concentrations of Montelukast: A Previously Unrecognized Role for CYP2C8 in the Metabolism of Montelukast." Clin Pharmacol Ther (2010):
Generic Name: montelukast
Brand name: Singulair
Synonyms: Singulair
Generic Name: ivacaftor / tezacaftor
Brand name: Symdeko, Symdeko 4-Week
Synonyms: Tezacaftor/ivacaftor and ivacaftor (Oral)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Singulair (Montelukast Tablets)-TGQ 30PSE/3BRM/15DM
- Singulair (Montelukast Tablets)-TGQ 7.5PEH/4BRM/15DM
- Singulair (Montelukast Tablets)-TGT First Aid Antibiotic
- Singulair (Montelukast Tablets)-TGT First Aid Cleansing
- Singulair (Montelukast Tablets)-TH Antibiotic + Pain Relief
- Singulair (Montelukast Tablets)-Thalidomide
- Tezacaftor/ivacaftor and ivacaftor-Sinografin
- Tezacaftor/ivacaftor and ivacaftor-Sinus & Allergy PE
- Tezacaftor/ivacaftor and ivacaftor-Sinus Congestion and Pain Daytime Cool Ice
- Tezacaftor/ivacaftor and ivacaftor-Sinus Nasal Spray
- Tezacaftor/ivacaftor and ivacaftor-Sinus Pain & Pressure
- Tezacaftor/ivacaftor and ivacaftor-Sinutab Ex-Strength